We look forward to welcoming you to Gene Therapy Analytical Development Europe on 1-3 September.
Please see our response to the COVID-19 outbreak here.

Optimising Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products

With hotly anticipated gene therapy clinical progress in Europe, Gene Therapy Analytical Development Europe will be the industry‘s definitive conference, designed to unite the analytical experts of gene therapy pharma and biotech to navigate the challenging regulatory landscape and develop robust analytical tools.

Following an extremely successful event in Boston, Gene Therapy Analytical Development Europe’s goal is to deliver an industry-focused event tailored specifically to the analytical challenges facing gene therapy developers, enabling ‘boots on the ground’ scientists to overcome their challenges to guarantee the consistency, quality and safety of gene therapy products.

Download the official event guide for more information.

"An outstanding opportunity to meet others in the field facing similar challenges and understand the proper path forward to ensure the safety and efficacy of gene therapy products."

Vertex Pharmaceuticals

"Extremely useful conference highly focused on the challenges facing analytics for gene therapy products."

Neurogene

Other Events in the Gene Therapy Series